Canica

The wealth originates from Norwegian discount retail and branded consumer goods. Stein Erik Hagen co-founded the RIMI grocery chain in the late 1970s, which later merged into the ICA group. He subsequently used the proceeds to build a controlling interest in Orkla, the Oslo-listed conglomerate that produces a wide range of consumer staples and holds significant industrial assets.

The firm operates with a split management structure. Jan Ole Stangeland serves as CEO of Canica in Norway, while Christer Kjos leads Canica's operations in Switzerland. Caroline Hagen Kjos, Stein Erik Hagen's daughter, chairs the board and represents the second-generation family leadership, ensuring the family's strategic priorities guide all investment decisions.

Canica is the single largest private shareholder of Orkla, the Oslo-listed branded consumer goods and industrial conglomerate. Stein Erik Hagen built this stake over decades. He also served as Orkla's chairman, giving Canica both a long-term financial interest in the company and a significant voice in its governance through board representation.

Canica does both. The firm makes direct real estate investments, owning several high-value commercial properties in central Oslo. It also allocates capital to private equity, public equities, and hedge funds, functioning as a hybrid direct investor and disciplined institutional allocator without a rigid separation between the two roles.

The portfolio is anchored in Norway, particularly in public equities and real estate. However, the firm's physical presence in Pfäffikon, Switzerland, and its engagement with global networks like the World Economic Forum suggest that Canica evaluates opportunities across Scandinavia, broader Europe, and in international hedge fund and private equity vehicles.

Yes, the family maintains the Stein Erik Hagen's Foundation for Urology and Cancer Research. This is a separate vehicle from the investment entity and reflects the family's structured approach to charitable giving, focusing on a specific medical field of interest to the founder.

The generational transition is actively managed. While Stein Erik Hagen remains the founder and primary owner, his daughter Caroline Hagen Kjos serves as Chairman of the Board, providing strategic oversight. Day-to-day deal work and asset management are delegated to professional chief executives based in Norway and Switzerland, allowing the family to focus on governance and long-term strategy.